F. Arndt

Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)

P. Merkel, F. Moosig, A. Hot, 2014, Annals of the rheumatic diseases.

HLA–DPB1 as a Risk Factor for Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Cohort Study

P. van Paassen, J. C. Cohen Tervaert, S. Wieczorek, 2016, Arthritis & rheumatology.

New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group

A. Vaglio, G. Emmi, C. Salvarani, 2019, Internal and Emergency Medicine.

Changes in the composition of the upper respiratory tract microbial community in granulomatosis with polyangiitis.

L. Burkhardt, P. Lamprecht, N. Fischer, 2019, Journal of autoimmunity.

International Consensus on ANCA Testing in Eosinophilic Granulomatosis with Polyangiitis.

Y. Shoenfeld, A. Vaglio, F. Moosig, 2020, American journal of respiratory and critical care medicine.

HLA–DPB1 as a Risk Factor for Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Cohort Study

P. van Paassen, J. C. Cohen Tervaert, S. Wieczorek, 2016, Arthritis & rheumatology.

New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group

A. Vaglio, G. Emmi, C. Salvarani, 2019, Internal and Emergency Medicine.

The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial.

F. Pieruzzi, B. Rovin, V. Strand, 2023, The Lancet. Rheumatology.